The Impact of Onset Age on Eosinophils in Kawasaki Disease

Yu-Jhen Chen1,2, Mindy Ming-Huey Guo1,2, Ling-Sai Chang1,2

  • 1Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.

Biomedicines
|April 23, 2022
PubMed

Insights

Kawasaki disease (KD) in young children is linked to eosinophil levels. Higher eosinophil counts in KD patients may increase the risk of coronary artery lesions, especially in infants under six months.

Area of Science:

  • Pediatrics
  • Immunology
  • Allergy

Background:

  • Kawasaki disease (KD) predominantly affects children under five.
  • Eosinophilia in KD patients may correlate with future allergic disease development.
  • Investigating the impact of onset age on eosinophil levels in KD is crucial.

Purpose of the Study:

  • To compare age-adjusted eosinophil Z-scores in Kawasaki disease patients.
  • To evaluate the influence of patient age at onset on eosinophil counts.
  • To assess the relationship between eosinophil levels and coronary artery lesions (CALs).

Main Methods:

  • Analysis of laboratory data from 398 Kawasaki disease patients.
  • Categorization of patients into seven age subgroups.
  • Comparison of age-adjusted eosinophil Z-scores across different disease phases.

Main Results:

  • Significant differences in absolute eosinophil counts were observed post-intravenous immunoglobulin (IVIG) and throughout KD, adjusted for age.
  • Persistent elevation of age-adjusted eosinophil Z-scores (Z-eosinophil) was noted, particularly in infants under six months.
  • Higher Z-eosinophil levels correlated with an increased risk of CALs, while lower levels correlated with a decreased risk.

Conclusions:

  • Clinicians should monitor for allergic diseases during KD follow-up, especially in infants under six months.
  • Eosinophil count serves as a critical indicator in managing Kawasaki disease.
  • Age-adjusted eosinophil levels offer insights into KD prognosis and potential complications.

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
762
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
606
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.7K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K